Stay updated on Tirzepatide in OSA: Clinical Trial
Sign up to get notified when there's something new on the Tirzepatide in OSA: Clinical Trial page.

Latest updates to the Tirzepatide in OSA: Clinical Trial page
- Check2 days agoChange DetectedA new Publications entry for Tirzepatide on obstructive sleep apnea-related cardiometabolic risk published in Nature Medicine (SURMOUNT-OSA) has been added.SummaryDifference0.0%

- Check9 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; this is a metadata version change with no impact on study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check31 days agoChange DetectedThe Locations section has expanded with additional participating sites across the US and internationally (e.g., across multiple states and regions, Australia, Brazil, China, Mexico, Puerto Rico, Japan, and more). Older location entries were removed/updated to reflect the new site list.SummaryDifference2%

- Check53 days agoChange DetectedA bibliographic entry for Sleep Med 2025 'Tirzepatide for sleep-disordered breathing in SURMOUNT-OSA: Time course and association with body weight' was added to the Publications section. The previous 'Online ahead of print' citation for the same article was removed.SummaryDifference0.0%

- Check60 days agoChange DetectedAdded a note that publications are auto-filled from PubMed and may not be about the study. Updated the revision label to v3.3.2.SummaryDifference0.1%

- Check67 days agoChange DetectedThe Taiwan site label was updated from 'Tainan City' to 'Tainan' (postal code 704) for the study location.SummaryDifference0.3%

Stay in the know with updates to Tirzepatide in OSA: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tirzepatide in OSA: Clinical Trial page.